Bank of America has affirmed its neutral rating on Oscar Health (OSCR).

Bank of America maintained its neutral rating on the company’s shares Oscar Health (NYSE:OSCR – Free Report) – according to MarketBeat.com, in a research note published on Thursday. The company’s stock currently has a price target of $21.00, down from the previous price target of $25.00.

OSCR has been the subject of many other reports. On Wednesday, February 21, TheStreet upgraded Oscar Health from the ad category to a C-. The Goldman Sachs Group increased their target price on Oscar Health from $16.00 to $21.00 and gave the company a Neutral rating in a research report on Thursday, May 9. Raymond James began coverage of Oscar Health in a research report on Friday, March 22. They issued an outperform rating and a $20.00 price target for the stock. Finally, Wells Fargo & Company increased their price target on Oscar Health from $20.00 to $24.00 and gave the stock an “overperform” rating in a research report on Thursday, May 9th. Three analysts have rated the company with a hold rating and four analysts have given the company a buy rating. Oscar Health currently has an average rating of “Moderate Buy” and a consensus price target of $18.57, according to MarketBeat.com.

Download our latest report on OSCR

Oscar Health stock results

On Thursday, NYSE OSCR began trading at $19.87. Oscar Health has a fifty-two week low of $4.72 and a fifty-two week high of $23.44. The company has a 50-day moving average price of $17.76 and a two-hundred-day moving average price of $13.76. The company has a debt to equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10.

Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, missing the analyst consensus estimate of $0.28 by $0.34. The company had revenue of $2.14 billion for the quarter, compared to analyst expectations of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. Oscar Health’s quarterly revenue increased 45.8% compared to the same quarter last year. During the same quarter last year, the company generated EPS ($0.18). On average, equity analysts predict that Oscar Health will post -0.04 EPS for the current fiscal year.

Institutional inflows and outflows

Institutional investors and hedge funds have recently modified their stake in the company. In the third quarter, Charles Schwab Investment Management Inc. increased its shares in Oscar Health shares by 19.3%. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company’s stock valued at $6,268,000 after purchasing an additional 182,206 shares in the last quarter. Graham Capital Management LP acquired a new position in shares of Oscar Health during the third quarter worth $894,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Oscar Health by 270.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 265,031 shares of the company’s stock valued at $2,425,000 after purchasing an additional 193,512 shares during the period. Dark Forest Capital Management LP acquired a new position in shares of Oscar Health in the 3rd quarter worth PLN 581,000. dollars. Finally, National Bank of Canada FI acquired a new position in shares of Oscar Health during the 4th quarter valued at $1,071,000. Institutional investors hold 75.70% of the company’s shares.

Oscar Health company profile

(Get the free report)

Oscar Health, Inc operates as an insurance company in the United States. The company offers health plans in the individual and small group markets, as well as +Oscar, a technology-enabled platform that helps providers and payers directly enable their transition to value-based care. It also offers reinsurance products.

Featured Stories

Get Oscar Health news and ratings every day – Enter your email address below to receive a daily concise summary of the latest news and analyst ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.